JPS5843075B2 - Method for producing α-D-galactosidase - Google Patents
Method for producing α-D-galactosidaseInfo
- Publication number
- JPS5843075B2 JPS5843075B2 JP3023081A JP3023081A JPS5843075B2 JP S5843075 B2 JPS5843075 B2 JP S5843075B2 JP 3023081 A JP3023081 A JP 3023081A JP 3023081 A JP3023081 A JP 3023081A JP S5843075 B2 JPS5843075 B2 JP S5843075B2
- Authority
- JP
- Japan
- Prior art keywords
- galactosidase
- enzyme
- culture
- elsinoe
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000005840 alpha-Galactosidase Human genes 0.000 title claims description 29
- 108010030291 alpha-Galactosidase Proteins 0.000 title claims description 29
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 244000005700 microbiome Species 0.000 claims description 11
- 241000125117 Elsinoe Species 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 description 25
- 108090000790 Enzymes Proteins 0.000 description 25
- 230000000694 effects Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 12
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 7
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 7
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 229930182830 galactose Natural products 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229920005654 Sephadex Polymers 0.000 description 5
- 239000012507 Sephadex™ Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000008351 acetate buffer Substances 0.000 description 4
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 3
- 235000021536 Sugar beet Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 3
- IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 241001564063 Elsinoe tiliae Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 238000001155 isoelectric focusing Methods 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241001156739 Actinobacteria <phylum> Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101100262441 Caenorhabditis elegans rfl-1 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241001569434 Elsinoe annonae Species 0.000 description 1
- 241000693108 Elsinoe araliae Species 0.000 description 1
- 241001568745 Elsinoe lepagei Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 101100341529 Oryza sativa subsp. japonica ITPK2 gene Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940124568 digestive agent Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- HOVAGTYPODGVJG-PZRMXXKTSA-N methyl alpha-D-galactoside Chemical compound CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-PZRMXXKTSA-N 0.000 description 1
- 230000006961 mixed inhibition Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000006959 non-competitive inhibition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
【発明の詳細な説明】
本発明は、エルシノエ属に属しα−D−ガラクトシダー
ゼ(EC3,2,1,22)産生能を有する微生物を栄
養培地で培養してα−D−ガラクトシダーゼを産生せし
めることを特徴とするα−Dガラクトシダーゼの製造方
法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention involves culturing a microorganism belonging to the genus Elsinoe and having the ability to produce α-D-galactosidase (EC3,2,1,22) in a nutrient medium to produce α-D-galactosidase. The present invention relates to a method for producing α-D galactosidase.
α−D−ガラクトシダーゼとは、メリビオース、ラフィ
ノース、スタキオースなどのα−ガラクトシドに作用し
、これをカ日水分解してガラクトースを遊離する酵素で
ある。α-D-galactosidase is an enzyme that acts on α-galactoside such as melibiose, raffinose, stachyose, etc., and decomposes it into dillic acid to liberate galactose.
これまでに植物、細菌、酵母、そしていくらかは高等植
物臓器由来のα−C−ガラクトシダーゼが知られており
、とりわけ糸状菌、放線菌、バクテリア由来のα−D−
ガラクトシダーゼは、従来より甜菜糖工業において、甜
菜より抽出した糖液中に含まれるラフィノースの分解に
用いられてきた。To date, α-C-galactosidases are known from plants, bacteria, yeasts, and some higher plant organs, and among others α-D-galactosidases from filamentous fungi, actinobacteria, and bacteria.
Galactosidase has traditionally been used in the sugar beet industry to decompose raffinose contained in sugar solution extracted from sugar beets.
しかし、いずれもα−D−ガラクトシターゼ力価が低く
、従って、その用途も上記のもの以外には、若干の研究
用途に限られていた。However, all of them have low α-D-galactosidase titers, and therefore their uses are limited to some research uses other than those mentioned above.
本発明者らは、強力なα−D−ガラクトシダーゼを産生
ずる微生物について精査した。The present inventors investigated microorganisms that produce potent α-D-galactosidase.
その結果、エルシノエ(Els 1noe )属に属す
る微生物が、αD−ガラクトシダーゼを容易に高活性で
産生じうろことを見いだし、本発明を完成した。As a result, it was discovered that a microorganism belonging to the genus Elsinoe can easily produce αD-galactosidase with high activity, and the present invention was completed.
以下、本発明のα−D−ガラクトシダーゼの諸性質につ
いて述べる。Below, various properties of α-D-galactosidase of the present invention will be described.
(1)作用
p−ニトロフェニル−α−D−4−y’)l−シト、メ
リビオース、ラフィノース、スタキオースなどのオリゴ
糖の他、α−ガラクトシド結合を含むグアガム、血液型
B物質にも作用し、ガラクトースを遊離する。(1) Action: In addition to oligosaccharides such as p-nitrophenyl-α-D-4-y')l-cyto, melibiose, raffinose, and stachyose, it also acts on guar gum and blood group B substances containing α-galactoside bonds. , liberating galactose.
(2)基質特異性
p−ニトロフェニル−α−Dガラクトシド、メリビオー
ス、ラフィノース、スタキオースをそれぞれ基質とし、
その濃度を変えることにより本酵素の反応速度変化を求
め、各基質についてLineweaver−Burk’
sプロットを作成した0そのプロットから求めた各基質
に対するKm値及びVmax値を第1表に示す。(2) Substrate specificity p-nitrophenyl-α-D galactoside, melibiose, raffinose, and stachyose, respectively, as substrates,
Changes in the reaction rate of this enzyme were determined by changing the concentration, and Lineweaver-Burk'
Table 1 shows the Km and Vmax values for each substrate determined from the s plot.
上記天然オリゴ糖以外に、グアガム、血液型B物質も基
質として用いると、グアガムに対しては3.2%(全糖
量に対し、ガラクトース換算)の、また血液型B物質に
対してはその全糖量に対し23%の分解率を示す。In addition to the above-mentioned natural oligosaccharides, when guar gum and blood group B substances are also used as substrates, the amount of guar gum is 3.2% (calculated as galactose based on the total sugar content), and the amount of blood group B substances is 3.2% (calculated as galactose). It shows a decomposition rate of 23% based on the total amount of sugar.
また、メチル−α−D−ガラクトシドには作用しない。Moreover, it does not act on methyl-α-D-galactoside.
(3)至適pHおよび安定pH領域
第1図及び第2図に示すように、本酵素は、pH4,5
付近に至適pHを有し、pH4〜10の領域で安定であ
る。(3) Optimal pH and stable pH range As shown in Figures 1 and 2, this enzyme
It has an optimum pH in the vicinity and is stable in the pH range of 4 to 10.
安定pH領域は、酵素20μlを予め所定のpHの緩衝
液(0,1M)200μl中、37°Cで2時間保った
後、残存活性を測定し求めた。The stable pH range was determined by storing 20 μl of the enzyme in 200 μl of a buffer (0.1M) at a predetermined pH for 2 hours at 37°C, and then measuring the residual activity.
(4)活性測定法
α−ガラクトシダーゼ活性は、p−ニトロフェニル−α
−D−ガラクトシドを基質として測定した。(4) Activity measurement method α-galactosidase activity is determined by p-nitrophenyl-α
-D-galactoside was used as a substrate for measurement.
即ち、適度に稀釈した酵素液0.1 ml、50mM基
質溶液0.01 ml、 0.1 M酢酸緩衝液(pH
4,s)o、ITLl、蒸留水0.29m1をカロえて
液量を0.5 rulとし、37℃で10分間反応させ
た。That is, 0.1 ml of appropriately diluted enzyme solution, 0.01 ml of 50 mM substrate solution, 0.1 M acetate buffer (pH
4,s)o, ITL1, and 0.29 ml of distilled water were added to make a liquid volume of 0.5 rul, and the mixture was reacted at 37°C for 10 minutes.
反応液に0.1MM酢酸緩衝液 pH8,2)を3.0
−加えて反応を停止させ、遊離したp−三トロフェノー
ルの黄色を420 nmの波長下で測定した。Add 0.1MM acetate buffer pH 8,2) to the reaction solution at 3.0
- the reaction was stopped and the yellow color of the liberated p-tritrophenol was measured under a wavelength of 420 nm.
この測定条件下において、1分間に1μモルの基質を加
水分解しうる酵素量を1単位(U)と定義する。Under these measurement conditions, the amount of enzyme that can hydrolyze 1 μmol of substrate per minute is defined as 1 unit (U).
(5)至適温度
第3図に示すように、各温度で15分間反応させたとき
の至適温度は、約50℃である。(5) Optimal temperature As shown in Figure 3, the optimal temperature when reacting at each temperature for 15 minutes is about 50°C.
(6)熱安定性
酵素液0.111Llに、pH4,5の0.1 M酢酸
緩衝液o、 i rfLlを加え所定の温度に1時間保
った後、残存活性を測定した。(6) To 0.111 Ll of thermostable enzyme solution was added 0.1 M acetate buffer o, i rfL1 at pH 4,5, and after keeping it at a predetermined temperature for 1 hour, the residual activity was measured.
結果は、第4図に示すように、50℃以下では安定であ
るが、それ以上の温度では徐々に失活する。As shown in FIG. 4, the result is that it is stable at temperatures below 50°C, but gradually loses its activity at temperatures above that temperature.
(7)阻害、活性化および安定化
Ag+2Mg2+、Pb2+、Fc3+とりわけp−C
MB、SDSにより著るしく阻害を受けるが、Uu2+
、Zn2+、Ca2+の影響は殆んどない。(7) Inhibition, activation and stabilization of Ag+2Mg2+, Pb2+, Fc3+ especially p-C
MB is significantly inhibited by SDS, but Uu2+
, Zn2+, and Ca2+ have almost no influence.
グルコース、マルトースは非拮抗阻害を示す。Glucose and maltose show non-competitive inhibition.
ガラクトース、ガラクツロン酸は低濃度(1〜2mM)
では拮抗阻害を示すが、高濃度(5〜10mM)では混
合型阻害を示す。Galactose and galacturonic acid at low concentrations (1-2mM)
shows competitive inhibition, but at high concentrations (5-10 mM) shows mixed inhibition.
各種金属塩および糖質による阻害状況を第2表および第
3表に示す。The inhibition status by various metal salts and carbohydrates is shown in Tables 2 and 3.
なお、第2表、第3表中の阻害率とは、阻害剤存在下ま
たは非存在下のα−D−グルコシダーゼ活性の阻害剤非
存在下のα−D−グルコシダーゼ活性(対照系)に対す
る百分率で示す。In addition, the inhibition rate in Tables 2 and 3 refers to the percentage of α-D-glucosidase activity in the presence or absence of an inhibitor relative to the α-D-glucosidase activity in the absence of an inhibitor (control system). Indicated by
また、本酵素の活性化剤および安定化剤はいまだ見い出
されていない。Furthermore, an activator and stabilizer for this enzyme have not yet been found.
(8)精製方法 通常の酵素と同様に精製できる。(8) Purification method It can be purified in the same way as regular enzymes.
その−例を実施例1に示す。An example thereof is shown in Example 1.
(9)分子量
第5図に示すように、セファデックスG−150(ファ
ルマシア社製、スエーデン国)および分子量が既知の4
種の蛋白質で検量線を作成し、本酵素の分子量を求めた
ところ220,000±20,000であった。(9) Molecular weight As shown in Figure 5, Sephadex G-150 (manufactured by Pharmacia, Sweden) and 4
A calibration curve was prepared using the various proteins, and the molecular weight of the enzyme was determined to be 220,000±20,000.
一方策6図のようにSDS電気泳動では60,000±
5,000の挙動を示し、四量体であると推定される。On the other hand, as shown in Figure 6, in SDS electrophoresis, 60,000±
5,000 and is estimated to be a tetramer.
(10)その他
未だ本酵素の結晶化に成功していないので、結晶構造を
示すことができない。(10) Others Since crystallization of this enzyme has not yet been successful, the crystal structure cannot be shown.
従って、これに代わる以下の理化学的性質を述べる。Therefore, we will describe the following physical and chemical properties in place of this.
(イ)紫外部吸収 275〜280nmに吸収帯を示す。(a) Ultraviolet absorption It shows an absorption band between 275 and 280 nm.
(0) 等重点
アンフオライン(LKB社製、スエーデン国)を用いる
等電点電気泳動法により測定したところ、pH3,0付
近に等電点を有する。(0) It has an isoelectric point near pH 3.0 as measured by isoelectric focusing using isofocusing ampholine (LKB, Sweden).
本願α−D−ガラクトシダーゼの製造方法に用いる微生
物には、エルシノエ属に属する微生物が有利に利用でき
る。Microorganisms belonging to the genus Yersinoe can be advantageously used as the microorganisms used in the method for producing α-D-galactosidase of the present invention.
例えば、Jenkins、 A、E、et al :
Arq。For example, Jenkins, A, E, et al:
Arq.
In5t、Biol、S、Paulo、417.67〜
72(1946)および高屋茂雄等:茶業技術研究第4
9号、79〜88(1975)等に報告され、工業技術
院微生物工業技術研究所へFERM−PA3874で寄
託されているエルシノエ ロイコスピーラ(Elsin
oe 1eucospila)は、本願発明のエルシナ
ンの製造に有利に利用できる。In5t, Biol, S, Paulo, 417.67~
72 (1946) and Shigeo Takaya et al.: Tea Industry Technology Research No. 4
9, No. 79-88 (1975), etc., and has been deposited with the Agency of Industrial Science and Technology's Institute of Microbial Technology under FERM-PA3874.
oe 1eucospila) can be advantageously used in the production of ercinane of the present invention.
同様に、エルシノエ アンペリーナ(Elsinoea
mpelina) IFo 5263、同IF0635
9、エルシノエ アラリアエ(Elsinoe ara
liae)IF06166、同IFO7162、エルシ
ノエフオーセツテイ(Elsinoe fawcett
i)IFO6442、同IFO8417、同ATCC1
32001エルシノエ アンノナエ(Elsinoe
annonae)ATCC15027、エルシノエ コ
ルニ(ElsinoeATCC11189、エルシノエ
へベアエ(Elsinoe heveae) ATC
C12570、エルシノエ レバゲイ(Elsinoe
lepagei)ATCC13008、エルシノエ
テイリアエ(Elsinoe tiliae) AT
CC24510などのエルシノエ属に属する微生物も、
本酵素の製造に有利に利用できる。Similarly, Elsinoea ampelina (Elsinoea ampelina)
mpelina) IFo 5263, IFo 0635
9. Elsinoe ara
liae) IF06166, same IFO7162, Elsinoe fawcett
i) IFO6442, IFO8417, ATCC1
32001 Elsinoe
annonae) ATCC15027, Elsinoe ATCC11189, Elsinoe heveae ATC
C12570, Elsinoe
lepagei) ATCC13008, Elsinoe tiliae (Elsinoe tiliae) AT
Microorganisms belonging to the genus Elsinoe, such as CC24510,
It can be advantageously used in the production of this enzyme.
微生物の培養は、通常の方法に準じ、液体培養、固体培
養などを行なえばよい。Microorganisms may be cultured by liquid culture, solid culture, etc. according to conventional methods.
液体培養の場合には静置培養でもよいが、振盪培養また
は通気攪拌培養の方が好ましい。In the case of liquid culture, static culture may be used, but shaking culture or aerated agitation culture is preferred.
培地としては、エルシノエ属に属する微生物が生育し、
α−D−ガラクトシダーゼを産生ずるものであれば、合
成、半合成、または天然のものと、そのいかんに拘わら
ず用いることができる。As a medium, microorganisms belonging to the genus Elsinoe grow,
Any synthetic, semi-synthetic, or natural substance that produces α-D-galactosidase can be used.
いずれの場合も、α−D−ガラクトシダーゼ産生を誘導
することが知られている。In either case, it is known that α-D-galactosidase production is induced.
ガラクトース、乳糖、ラフィノース、メリビオース、ソ
ルビトール、マルチトールなどを含有する培地か、ある
いは培地にこれを添加して培養し、酵素産生量を増大せ
しめるのが好ましい。It is preferable to increase enzyme production by culturing in a medium containing galactose, lactose, raffinose, melibiose, sorbitol, maltitol, etc., or by adding these to the medium.
特に微生物生育用炭素源にソルビトールやマルチトール
を使用すれば、産生されたα−D−ガラクトシダーゼは
、その殆んどが菌体外に放出されるので、粘質物を除去
することなく培養物をそのまま酵素液として使用でき好
都合である。In particular, if sorbitol or maltitol is used as a carbon source for growing microorganisms, most of the produced α-D-galactosidase will be released outside the microbial cells, so the culture can be grown without removing mucilage. It is convenient because it can be used as it is as an enzyme solution.
一般に培地のpHを5〜8とし、これにエルシノエ属に
属する微生物を植菌し、20〜35℃で0.5〜10日
間培養する。Generally, the pH of the medium is adjusted to 5 to 8, microorganisms belonging to the genus Elsinoe are inoculated, and cultured at 20 to 35°C for 0.5 to 10 days.
このようにして得た培養物は、そのまま酵素剤として用
いることもできるが、培養物から菌体を分離した後、菌
体から酵素を抽出し、これを粗酵素液として用いること
もできる。The culture thus obtained can be used as it is as an enzyme preparation, but after separating the bacterial cells from the culture, the enzyme can be extracted from the bacterial cells and used as a crude enzyme solution.
また、公知の精製分離法、例えば、塩析、透析、濾過、
遠心分離、濃縮、凍結乾燥などを行なうことによって容
易に精製分離し、採取することができる。In addition, known purification separation methods such as salting out, dialysis, filtration,
It can be easily purified and separated and collected by centrifugation, concentration, freeze-drying, etc.
更に、高度の精製を必要とする場合には、例えば、イオ
ン交換体への吸着・脱着、ゲル濾過およびアフィニティ
ークロマトグラフィー、等電点分画、電気泳動などの公
知蛋白質精製法を更に組み合わせればよく、最高純度の
α−D−ガラクトシダーゼ標品を採取することも可能で
ある。Furthermore, if a high degree of purification is required, it is possible to further combine known protein purification methods such as adsorption/desorption to ion exchangers, gel filtration, affinity chromatography, isoelectric focusing, and electrophoresis. It is often possible to obtain α-D-galactosidase preparations of the highest purity.
本発明の方法により製造したα−D−ガラクトシダーゼ
は、従来通り甜菜糖液中のラフィノース分解、定量用酵
素剤、化合物の構造決定用試薬などの各種試験用途およ
び消化剤などの医療用途はもとより、免疫化学的研究用
試薬や、例えば血液など生理活性物質の改質剤などとし
ても有利に利用できる。The α-D-galactosidase produced by the method of the present invention can be used not only for various test purposes such as raffinose decomposition in sugar beet solution, quantitative enzyme agent, and reagent for determining the structure of compounds, but also for medical purposes such as digestive agents. It can also be advantageously used as a reagent for immunochemical research or as a modifier for physiologically active substances such as blood.
また、本発明によるα−D−ガラクトシダーゼは、その
ままでも安定であるが、これに公知方法により、化学的
修飾を施して、更に安定化を計ることも、また公知固定
化法により酵素の安定化を計るとともに、反復利用し、
上記用途において更に有利に使用することも自由である
。Although the α-D-galactosidase according to the present invention is stable as it is, it may be chemically modified by a known method to further stabilize the enzyme, or the enzyme can be stabilized by a known immobilization method. Measure and use repeatedly,
It is also free to use it more advantageously in the above applications.
以下、2〜3の実施例を挙げて本発明を説明する。The present invention will be described below with reference to a few examples.
実施例 1
蔗糖5w/v%、(NH4) 2 SO40,3vi/
v 1:l:、、酵母エキス0.5 w/v %、ペプ
トン0.5w/v%、K 2HPO40,2w/v%、
Mg5O,−7H20o、 05 W/V %、Mn
SO4・4〜6H200,OO2w/v%、FeSO4
・7H200,001w/v%を含有する培地61をジ
ャーファーメンタ−にとり、120℃に20分間保って
滅菌した。Example 1 Sucrose 5w/v%, (NH4)2SO40,3vi/
v 1:l:, yeast extract 0.5 w/v%, peptone 0.5w/v%, K2HPO40.2w/v%,
Mg5O, -7H20o, 05 W/V%, Mn
SO4・4~6H200, OO2w/v%, FeSO4
- Medium 61 containing 200,001 w/v% of 7H was placed in a jar fermentor and kept at 120°C for 20 minutes to sterilize it.
冷却後、培地の始発pHを6.7とした後、エルシノエ
・ロイコスピラFERM−P慮3874を植菌し、24
°Cで毎分300回転、61通気下で6日間培養した。After cooling, the initial pH of the medium was set to 6.7, and then inoculated with Elsinoe leukospira FERM-P 3874.
The cells were cultured at 300°C for 6 days under 61°C aeration.
培養液を遠心分離して集菌し、超音波処理(20KHz
、10分間)した菌体から酵素を抽出した。The culture solution was centrifuged to collect bacteria, and sonicated (20KHz).
, 10 minutes), the enzyme was extracted from the bacterial cells.
この粗酵素液を0.05MIJン酸緩衝液pH6,0で
平衡化させたDEAE−セファデックスA−50イオン
交換体ゲル(ファルマシア社製、スエーデン国)20g
と共にゆるく攪拌し、酵素蛋白を吸着せしめた。20 g of DEAE-Sephadex A-50 ion exchange gel (manufactured by Pharmacia, Sweden) in which this crude enzyme solution was equilibrated with 0.05 MIJ acid buffer pH 6.0.
The mixture was stirred gently to adsorb the enzyme protein.
溶出は0.1MNaC1を含む同じ0.05MIJン酸
緩衝液pH6,0にて行ない、3回の溶出により96.
4%の活性回収率を得た。Elution was performed with the same 0.05 MIJ acid buffer pH 6.0 containing 0.1 M NaCl, and three elutions were performed to obtain a concentration of 96.
An activity recovery of 4% was obtained.
ついで、この溶出液を0.05MIJン酸緩衝液pH6
,0に透析し、同じ<DEAE−セファデックスA−5
0イオン交換ゲルカラムで分画した。This eluate was then diluted with 0.05 MIJ acid buffer pH 6.
, 0, same <DEAE-Sephadex A-5
0 ion exchange gel column.
α−D−ガラクトシダーゼ活性画分を限外濾過(東洋濾
紙UHP−76フイルター UK−10)及びコロジオ
ンバッグで濃縮した。The α-D-galactosidase active fraction was concentrated using ultrafiltration (Toyo Roshi UHP-76 filter UK-10) and a collodion bag.
濃縮液をセファデックスG−100ゲル(ファルマシア
社製、スエーデン国)を充填したカラムで分画した。The concentrated solution was fractionated using a column filled with Sephadex G-100 gel (manufactured by Pharmacia, Sweden).
活性画分を0.05M酢酸緩衝液、pH4,5に5時間
透析した。The active fraction was dialyzed against 0.05M acetate buffer, pH 4,5 for 5 hours.
上記方法で濃縮した酵素液を、今度は、CM−セルロー
ス(ワットマン社製、英国)を充填したカラムで処理し
、α−D−ガラクトシダーゼ活性は非吸着画分に回収さ
れた。The enzyme solution concentrated by the above method was then treated with a column packed with CM-cellulose (Whatman, UK), and α-D-galactosidase activity was recovered in the non-adsorbed fraction.
以上の精製工程を第4表に一覧した。The above purification steps are listed in Table 4.
この表からも明らかなように、この精製工程により比活
性は約170倍に増高し、このときの活性回収率は約4
8.1%であった。As is clear from this table, this purification step increases the specific activity by about 170 times, and the activity recovery rate at this time is about 4.
It was 8.1%.
実施例 2
実施例1の培地において、蔗糖に代えラフィノースを用
いて調製した培地を用いた以外は、実施例1と同様にし
て培養し、α−D−ガラクトシダーゼを産生せしめた。Example 2 Culture was carried out in the same manner as in Example 1 except that a medium prepared using raffinose instead of sucrose was used to produce α-D-galactosidase.
実施例と同様に菌体を集菌・遠心分離した後、超音波処
理した菌体から酵素を抽出し、上清中のα−D−ガラク
トシダーゼ活性を測定した。After collecting and centrifuging the cells in the same manner as in Examples, the enzyme was extracted from the sonicated cells, and the α-D-galactosidase activity in the supernatant was measured.
培養物1mlあたりのα−D−ガラクトシダーゼ産生量
は約2.1単位であった。The amount of α-D-galactosidase produced per ml of culture was approximately 2.1 units.
実施例 3
ソルビトール2w/v%、酵母エキス0.5 w/vφ
、NaN0a O,2w/v %、K2HPO40,0
42w/v %、KH2PO40,018w/v %を
含有する培地201をジャーファーメンタ−にとり、1
20℃に20分間保って滅菌した。Example 3 Sorbitol 2 w/v%, yeast extract 0.5 w/vφ
, NaN0a O,2w/v %, K2HPO40,0
42 w/v %, KH2PO 40,018 w/v % was placed in a jar fermentor, and 1
It was sterilized by keeping it at 20°C for 20 minutes.
冷却後、培地の始発pH6,5としてエルシノエ・アラ
リアエIF06166を植菌し、25℃で5日間通気攪
拌培養した。After cooling, Yersinoe arariae IF06166 was inoculated at an initial pH of 6.5 and cultured with aeration at 25° C. for 5 days.
培養終了後、培養物を遠心分離し、上清中のα−D−ガ
ラクトシダーゼ活性を測定した。After completion of the culture, the culture was centrifuged, and α-D-galactosidase activity in the supernatant was measured.
培養物1rILlあたりのα−D−ガラクトシダーゼ産
生量は約1.5単位であった。The amount of α-D-galactosidase produced per 1 rIL of culture was approximately 1.5 units.
第1図は、至適pHを示す図である。
第2図は、安定pH領域を示す図である。
第3図は、至適温度を示す図である。
第4図は、安定温度領域を示す図である。
第5図は、セファデックスG−150による分子量の検
量線とα−D−ガラクトシダーゼの分子量を示す図であ
る。
第6図は、SDS電気泳動による分子量の検量線とα−
D−ガラクトシダーゼの分子量を示す図である。FIG. 1 is a diagram showing the optimum pH. FIG. 2 is a diagram showing a stable pH region. FIG. 3 is a diagram showing the optimum temperature. FIG. 4 is a diagram showing a stable temperature region. FIG. 5 is a diagram showing a molecular weight calibration curve using Sephadex G-150 and the molecular weight of α-D-galactosidase. Figure 6 shows the molecular weight calibration curve and α-
It is a figure showing the molecular weight of D-galactosidase.
Claims (1)
能を有する微生物を栄養培地で培養してα−D−ガラク
トシダーゼを産生せしめ、これを採取することを特徴と
するα−D−ガラクトシダーゼの製造方法。1. A method for producing α-D-galactosidase, which comprises culturing a microorganism belonging to the genus Elsinoe and having the ability to produce α-D-galactosidase in a nutrient medium to produce α-D-galactosidase, and collecting the same.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3023081A JPS5843075B2 (en) | 1981-03-03 | 1981-03-03 | Method for producing α-D-galactosidase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3023081A JPS5843075B2 (en) | 1981-03-03 | 1981-03-03 | Method for producing α-D-galactosidase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57144982A JPS57144982A (en) | 1982-09-07 |
| JPS5843075B2 true JPS5843075B2 (en) | 1983-09-24 |
Family
ID=12297901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3023081A Expired JPS5843075B2 (en) | 1981-03-03 | 1981-03-03 | Method for producing α-D-galactosidase |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5843075B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0472588B2 (en) † | 1989-05-16 | 2002-01-02 | Block Drug Company, Inc. | Use of alpha-d-galactosidase for the preparation of a pharmaceutical composition for reducing gastro-intestinal distress due to alpha-d-galactoside-linked sugars. |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2640941B2 (en) * | 1987-06-15 | 1997-08-13 | 天野製薬株式会社 | Method for stopping enzyme activity of galactosidase |
-
1981
- 1981-03-03 JP JP3023081A patent/JPS5843075B2/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0472588B2 (en) † | 1989-05-16 | 2002-01-02 | Block Drug Company, Inc. | Use of alpha-d-galactosidase for the preparation of a pharmaceutical composition for reducing gastro-intestinal distress due to alpha-d-galactoside-linked sugars. |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57144982A (en) | 1982-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kobayashi et al. | Purification and some properties of Bacillus macerans cycloamylose (cyclodextrin) glucanotransferase | |
| EP0024182B1 (en) | Thermo-stable micro-organism and proteolytic enzyme prepared therefrom, and processes for the preparation of the micro-organism and the proteolytic enzyme | |
| CA1133410A (en) | Enzymes and processes utilising enzymes | |
| US4064010A (en) | Purification of uricase | |
| US4678750A (en) | Method and compositions for use in the treatment of fireblight | |
| JP3523285B2 (en) | Production method for glycolytic enzymes | |
| EP0036737A2 (en) | Lactase preparation | |
| Rokop et al. | Purification and characterization of fully deuterated enzymes | |
| JPH0236230B2 (en) | ||
| JPH0440987B2 (en) | ||
| JPS5843075B2 (en) | Method for producing α-D-galactosidase | |
| US4062731A (en) | Production of uricase from micrococcus luteus | |
| JPS61187787A (en) | Polypeptide product | |
| US4581332A (en) | Novel alkaline protease | |
| JPS6279777A (en) | Production of superoxide dismutase | |
| Islam et al. | Purification and properties of an extracellular proteolytic enzyme from Bacillus cereus | |
| JPH0480675B2 (en) | ||
| JPH0998779A (en) | Trehalose synthase, method for producing the same, and method for producing trehalose using the same | |
| US4783406A (en) | Method and compositions for use in the treatment of fireblight | |
| JPH07289256A (en) | Aminopeptidase and method for producing the same | |
| JPH04365473A (en) | Cryptococcus laurenty dsm2762 | |
| SU1406160A1 (en) | Method of producing restriction endonuclease fok i from flavobacterium okeanokoites | |
| JPH07106148B2 (en) | Novel enzyme having agarase activity, method for producing the same, and novel microorganism producing the enzyme | |
| JP3125954B2 (en) | Novel phosphoenolpyruvate carboxylase and its preparation | |
| JPS58152482A (en) | Heat-resistant proteolytic enzyme aqualysin i and preparation thereof |